MedPath

Hemodynamic Comparison of Peripheral and Central VA ECMO.

Recruiting
Conditions
Cardiac Arrest
Hemodynamics Instability
Extracorporeal Circulation; Complications
Shock, Cardiogenic
Interventions
Procedure: Veno-arterial extracorporeal membrane oxygenation
Registration Number
NCT05669183
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Brief Summary

The goal of this clinical trial is to monitor hemodynamic differences between central veno-arterial extracorporeal membrane oxygenation (VA ECMO) and peripheral VA ECMO. The main question it aims to answer is:

* Efficacy of the different cannulation strategies for the establishment of for VA-ECMO circulation on hemodynamics and organ perfusion.

Participants require VA ECMO support, will be divided into two groups in an intention-to-treat analysis: central artery cannulation and peripheral artery cannulation.

Researchers will analyze different cannulation strategies for VA-ECMO and identify potential advantages and disadvantages for two groups of VA-ECMO.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
136
Inclusion Criteria
  • Age≄18 years
  • Participants with cardiogenic shock
  • Obtaining informed consent from participants or their affiliated beneficiaries
Exclusion Criteria
  • Irreversible heart failure
  • Contraindications to anticoagulation therapy
  • Uncontrolled bleeding
  • Irreversible neurological pathology
  • Participants limited to extracorporeal cardiopulmonary resuscitation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Central VA ECMOVeno-arterial extracorporeal membrane oxygenationAxillary artery cannulation for veno-arterial extracorporeal membraneous oxygenation (VA ECMO)
Peripheral VA ECMOVeno-arterial extracorporeal membrane oxygenationFemoral artery cannulation for veno-arterial extracorporeal membraneous oxygenation (VA ECMO)
Primary Outcome Measures
NameTimeMethod
Left ventricular end-diastolic volume (ml)Through VA ECMO support completion, an average of 1 week

echocardiography

Mitral valve area(cm2)Through VA ECMO support completion, an average of 1 week

echocardiography

Oxygen saturation-no. (%)Through VA ECMO support completion, an average of 1 week

Blood gas analysis

Left ventricular End-systolic volume (ml)Through VA ECMO support completion, an average of 1 week

echocardiography

Stroke volume (ml)Through VA ECMO support completion, an average of 1 week

echocardiography

Secondary Outcome Measures
NameTimeMethod
Duration of ICU stayThrough study completion, up to 2 years

Intensive care unit length of stay

Duration of hospital stayThrough study completion, up to 2 years

Length of hospital stay

VA ECMO durationThrough VA ECMO support, an average of 1 week

Length of VA ECMO support

Cannulation-related complicationsThrough study completion, up to 2 years

Cannulation-related complications include bleeding, limb ischemia, revision of cannulation site, wound complications. Limb ischemia is defined as ischemia requiring any surgical procedure, including revision of the arterial/distal perfusion cannula, fasciotomy for compartment syndrome, gangrene, or amputation. Wound complication is defined as infection or requirement of an additional surgical intervention, such as arterial repair, washout with or without vacuum-assisted closure, and muscle flap closure.

Rate of successful weaning from VA ECMOThrough study completion, up to 2 years

Weaning success is defined as survival after complete removal of the extracorporeal circuit without requirement for further mechanical support or heart transplant.

Trial Locations

Locations (1)

First Affiliated Hospital of Xi'an Jiaotong University

šŸ‡ØšŸ‡³

Xi'an, Shaanxi, China

Ā© Copyright 2025. All Rights Reserved by MedPath